Intravenous Iron Therapy

Medicare covers intravenous sodium ferric gluconate complex in sucrose and iron sucrose as first-line treatments for iron deficiency anemia only for patients undergoing chronic hemodialysis who are receiving supplemental erythropoietin therapy. Coverage is limited to these IV products and this specific patient population; other products or patients not meeting both conditions require individual review.

"Sodium ferric gluconate complex in sucrose injection is covered as a first-line intravenous treatment for iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supple..."

Sign up to see full coverage criteria, indications, and limitations.